These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1868265)

  • 1. Inorganic supports coated with N-substituted polyacrylamides: application to biospecific chromatography of proteins.
    Ivanov AE; Kozlov LV; Shojbonov BB; Zubov VP; Antonov VK
    Biomed Chromatogr; 1991 Mar; 5(2):90-3. PubMed ID: 1868265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Binding and activation of the first component of human complement on artificial matrices].
    Kozlov LV; Sizoĭ MN; Zinchenko AA; Ivanov AE; Zubov VP
    Bioorg Khim; 1984 Dec; 10(12):1629-38. PubMed ID: 6529444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favourable biospecific reactivity of blood group B antigenic trisaccharide chemically attached to poly-N-(2-hydroxyethyl)acrylamide-coated porous glass.
    Ivanov AE; Bovin NV; Korchagina EYu ; Zubov VP
    Biomed Chromatogr; 1992; 6(1):39-42. PubMed ID: 1600373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
    Kolb WP; Kolb LM; Podack ER
    J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of a previously unrecognized subcomponent of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):482-7. PubMed ID: 807639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
    Belozerov AP
    Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin adsorption on coated silica based supports grafted with N-acetylglucosamine by liquid affinity chromatography.
    Lakhiari H; Muller D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 808(1):35-41. PubMed ID: 15236683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification from euglobulin of the first component (C1) of complement and its subcomponents by heparin-sepharose chromatography.
    von Zeipel G; Hanson HS; von Stedingk LV
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):123-30. PubMed ID: 855665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of the first component of human complement.
    Reid KB
    Immunodefic Rev; 1989; 1(3):247-60. PubMed ID: 2561058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.